| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 04/07/2005 | WO2005030151A2 Compounds and compositions as protein kinase inhibitors |
| 04/07/2005 | WO2005030150A2 9,10-α,α-OH-TAXANE ANALOGS AND METHODS FOR PRODUCTION THEREOF |
| 04/07/2005 | WO2005030149A2 Suppression of hiv replication for prevention and treatment of hiv |
| 04/07/2005 | WO2005030148A2 Tetrahydroindolone derivatives for treatment of neurological conditions |
| 04/07/2005 | WO2005030147A2 Methods of using ammonia oxidizing bacteria |
| 04/07/2005 | WO2005030146A2 Calcium dietary supplement |
| 04/07/2005 | WO2005030145A2 Composition and pharmacology of novel alpha-6-containing nicotinic acetylcholine receptors |
| 04/07/2005 | WO2005030143A2 Chelerythrine, analogs thereof and their use in the treatment of bipolar disorder and other cognitive disorders |
| 04/07/2005 | WO2005030142A2 Rifalazil formulations |
| 04/07/2005 | WO2005030141A2 Morinda citrifolia-based oral care compositions and methods |
| 04/07/2005 | WO2005030140A2 C-met modulators and methods of use |
| 04/07/2005 | WO2005030139A2 Seneca valley virus based compositions and methods for treating disease |
| 04/07/2005 | WO2005030138A2 Methods of modulating inflammatory reactions by modulating xanthine oxidoreductase activity |
| 04/07/2005 | WO2005030137A2 Improving biomechanical performance of irradiated biological material |
| 04/07/2005 | WO2005030136A2 Tumor vaccine |
| 04/07/2005 | WO2005030135A2 Nitrosated glutamic acid compounds, compositions and methods of use |
| 04/07/2005 | WO2005030134A2 Relationship of a specific metabolite to insulin resistance |
| 04/07/2005 | WO2005030133A2 Treatment with agonists of toll-like receptors |
| 04/07/2005 | WO2005030131A2 Bis-quinazoline compounds for the treatment of bacterial infections |
| 04/07/2005 | WO2005030130A2 Isoquinoline potassium channel inhibitors |
| 04/07/2005 | WO2005030129A2 Quinoline potassium channel inhibitors |
| 04/07/2005 | WO2005030128A2 Pyrazole modulators of metabotropic glutamate receptors |
| 04/07/2005 | WO2005030127A2 Novel crystalline form of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor |
| 04/07/2005 | WO2005030126A2 Adhesin-specific nanoparticles and process for using same |
| 04/07/2005 | WO2005030125A2 Method of treating smallpox and monkeypox |
| 04/07/2005 | WO2005030122A2 Inactivated host cell delivery of polynucleotides encoding immunogens |
| 04/07/2005 | WO2005030121A2 Compounds, compositions and methods |
| 04/07/2005 | WO2005030120A2 Antiangiogenic agents |
| 04/07/2005 | WO2005009395A3 Cellulosic fiber containing composition |
| 04/07/2005 | WO2005009393A3 Stable radiopharmaceutical compositions and methods for preparation |
| 04/07/2005 | WO2005009362A3 Muscarinic acetylcholine receptor antagonists |
| 04/07/2005 | WO2005007094A3 Asthma and allergic inflammation modulators |
| 04/07/2005 | WO2005000249A3 Preparation of chemical compounds |
| 04/07/2005 | WO2005000217A3 Combination therapy for the treatment of dyslipidemia |
| 04/07/2005 | WO2005000195A3 A pretreatment or post exposure treatment for exposure to a toxic substance by pulmonary delivery (inhaler) of a bioscavenger |
| 04/07/2005 | WO2004112719A3 Chemical compounds |
| 04/07/2005 | WO2004112718A3 Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases |
| 04/07/2005 | WO2004112715A3 Methods of making and using theaflavin,theaflavin-3-gallate, theaflavin-3’-gallate and theaflavin 3,3’ - digallate and mixtures thereof |
| 04/07/2005 | WO2004112714A3 Chemical compounds |
| 04/07/2005 | WO2004112709A3 Inhibitors of cathepsin s |
| 04/07/2005 | WO2004112695A3 Methods and compositions for delivery of catecholic butanes for treatment of obesity |
| 04/07/2005 | WO2004110364A9 Thiotungstate analogues and uses thereof |
| 04/07/2005 | WO2004103281A3 Vanilloid receptor antagonists, and methods of making and using them |
| 04/07/2005 | WO2004096155A3 Tablets and methods for modified release of hydrophilic and other active agents |
| 04/07/2005 | WO2004096130A3 Inhibitors of akt activity |
| 04/07/2005 | WO2004093806A3 Compounds for the treatment of metabolic disorders |
| 04/07/2005 | WO2004093795A3 Compositions for delivery of drug combinations |
| 04/07/2005 | WO2004091538A3 Homogeneous, thermoreversible alginate films and soft capsules made therefrom |
| 04/07/2005 | WO2004091513A3 9-aminomethyl substituted minocycline compounds |
| 04/07/2005 | WO2004091488A3 Estrogen receptor modulators |
| 04/07/2005 | WO2004075859A3 Treatment of canine hemangiosarcoma with a histone deacetylase inhibitor |
| 04/07/2005 | WO2004066957A3 ANTI-INTEGRIN ανβ3 ANTIBODY FORMULATIONS AND USES THEREOF |
| 04/07/2005 | WO2004066953A3 Polymerized hemoglobin solutions having reduced amount of tetramer and method for preparing |
| 04/07/2005 | WO2004062590A3 Bicyclic carbohydrates as antiprotozoal bioactive for the treatment of infections caused by parasites |
| 04/07/2005 | WO2004019887A3 Nosebleed lip pack |
| 04/07/2005 | US20050075599 Ultrasonically enhanced saline treatment for burn damaged skin |
| 04/07/2005 | US20050075398 Neuroprotectin D1 protects against cellular apoptosis, stroke damage, alzheimer's disease and retinal diseases |
| 04/07/2005 | US20050075375 Drugs as viricides for hepatitis C with carriers |
| 04/07/2005 | US20050075369 Novel form of S-omeprazole |
| 04/07/2005 | US20050075341 Administering benzenesulfonamide, alkylsulfonylbenzene, benzopyran, benzothiopyran, dihydroquinoline, and/or 2-(anilino-)benzeneacetic acid derivatives |
| 04/07/2005 | US20050075335 Pharmaceutical composition comprising n((1-n-butyl-4-piperidinyl)methyl)-3,4-dihydro-2h-(1,3)oxazino(3,2-a)indole-10-carboxamide or salt and process therefor comprising dry granulation |
| 04/07/2005 | US20050075312 Antitumor inhibitors and use thereof |
| 04/07/2005 | US20050075277 Use of lactoferrin in prophylaxis against infection and/or inflammation in immunosuppressed subjects |
| 04/07/2005 | US20050074877 Joint propagated on biological scaffold for use in treatment and prevention of degenerative bone disorders; tissue engineering and regenerative medicine |
| 04/07/2005 | US20050074814 Relaxin3-GPCR135 complexes and their production and use |
| 04/07/2005 | US20050074474 Porous spherical disintegrative silica impregnated with water insoluble skin benefit agent in carrier; smooth, nongreasy feel; performance; low cost, shelf life |
| 04/07/2005 | US20050074451 Synergistic combination of methotrexate with antibody to alpha 4 integrin or immunologically active antigen binding fragment |
| 04/07/2005 | US20050074447 Treatment for diabetic microvascular and macrovascular complications |
| 04/07/2005 | US20050074408 Compounds for fluorescent emission for animals |
| 04/07/2005 | US20050071933 at least one monoazo or ethenylene pyridine and aniline dye; intense and slightly selective colors with improved radiation resistance and colorfastness |
| 04/07/2005 | CA2744997A1 C-met modulators and method of use |
| 04/07/2005 | CA2580730A1 Tetrahydroindolone derivatives for treatment of neurological conditions |
| 04/07/2005 | CA2550722A1 Calcium dietary supplement |
| 04/07/2005 | CA2540518A1 Compounds and compositions as protein kinase inhibitors |
| 04/07/2005 | CA2540283A1 Tumor vaccine |
| 04/07/2005 | CA2540177A1 Seneca valley virus based compositions and methods for treating disease |
| 04/07/2005 | CA2540151A1 Chelerythrine, analogs thereof and their use in the treatment of bipolar disorder and other cognitive disorders |
| 04/07/2005 | CA2539974A1 Methods of using ammonia oxidizing bacteria |
| 04/07/2005 | CA2539973A1 Nitrosated glutamic acid compounds, compositions and methods of use |
| 04/07/2005 | CA2539233A1 Morinda citrifolia-based oral care compositions and methods |
| 04/07/2005 | CA2537812A1 C-met modulators and method of use |
| 04/07/2005 | CA2530679A1 Compounds for treating angiogenesis |
| 04/07/2005 | CA2527074A1 Antiangiogenic agents |
| 04/06/2005 | EP1520050A2 Tr4/tr2 response elements |
| 04/06/2005 | EP1519920A1 Novel tetrahydropyridine derivatives as renin inhibitors |
| 04/06/2005 | CN1604790A Treatment of sepsis by low dose administration of tissue factor pathway inhibitor (tfpi) |
| 04/06/2005 | CN1604787A Treatment of sepsis by low dose administration of tissue factor pathway inhibitor (TFPI) |
| 04/06/2005 | CN1604786A Anti-hsv agent for inhibiting replication of HSV-1 and HSV-2 and method of producing a substance having anti-HSV activity |
| 04/06/2005 | CN1604780A Use of rosuvastatin in pre demented states |
| 04/06/2005 | CN1604777A Method of treatment |
| 04/06/2005 | CN1603291A Novel intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 04/06/2005 | CN1602880A Method for inhibitting bone resorption |
| 04/06/2005 | CN1602879A Method for inhibitting bone resorption |
| 04/06/2005 | CN1195762C Novel 2-(iminomethyl) amino-phenyl derivatives, preparation, application as medicines and compositions containing same |
| 04/06/2005 | CN1195743C Dihydro-1, 3, 5-triazine amine derivatives and their therapeutic uses |
| 04/06/2005 | CN1195492C 皮肤护理组合物 Skin care compositions |
| 04/06/2005 | CN1195483C Stable hydrogenated lupulone antibacterial oral compositions |
| 04/06/2005 | CN1195480C Oxidation dyeing composition for keratin fibers and dyeing method using said composition |
| 04/05/2005 | US6875446 Method for prophylaxis and/or treatment of thromboembolism |
| 03/31/2005 | WO2005027856A2 Inhibitors of anthrax lethal factor |